Veracyte, Inc. (VCYT)
43.64
+2.17
(+5.23%)
USD |
NASDAQ |
Aug 25, 15:16
Veracyte Price : 43.64 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 42.00 | 42.07 | 41.02 | 41.47 | 1.165M |
| Aug 21, 2026 | 42.18 | 42.54 | 41.10 | 42.31 | 1.005M |
| Aug 20, 2026 | 41.67 | 42.44 | 41.05 | 41.79 | 980364.0 |
| Aug 19, 2026 | 41.92 | 42.52 | 40.10 | 42.19 | 1.762M |
| Aug 18, 2026 | 41.80 | 42.35 | 40.35 | 40.68 | 1.144M |
| Aug 17, 2026 | 40.96 | 42.50 | 40.96 | 42.08 | 1.574M |
| Aug 14, 2026 | 42.54 | 43.12 | 41.00 | 41.25 | 1.669M |
| Aug 13, 2026 | 45.23 | 45.23 | 42.51 | 42.60 | 1.455M |
| Aug 12, 2026 | 46.54 | 46.76 | 44.28 | 44.68 | 874116.0 |
| Aug 11, 2026 | 46.07 | 46.67 | 45.72 | 46.41 | 551006.0 |
| Aug 10, 2026 | 46.87 | 47.75 | 46.12 | 46.27 | 761912.0 |
| Aug 07, 2026 | 47.00 | 47.80 | 46.21 | 47.22 | 821473.0 |
| Aug 06, 2026 | 45.80 | 46.53 | 45.16 | 46.15 | 939859.0 |
| Aug 05, 2026 | 46.07 | 47.96 | 45.92 | 46.15 | 1.228M |
| Aug 04, 2026 | 44.84 | 46.57 | 43.09 | 46.41 | 1.987M |
| Aug 03, 2026 | 46.36 | 47.32 | 44.80 | 44.85 | 2.011M |
| Jul 31, 2026 | 48.77 | 50.17 | 43.52 | 46.32 | 5.995M |
| Jul 30, 2026 | 55.36 | 59.96 | 54.73 | 59.78 | 1.551M |
| Jul 29, 2026 | 56.03 | 57.55 | 55.07 | 55.71 | 929259.0 |
| Jul 28, 2026 | 55.60 | 56.63 | 54.72 | 55.65 | 740194.0 |
| Jul 27, 2026 | 57.78 | 58.09 | 55.21 | 55.61 | 748902.0 |
| Jul 24, 2026 | 58.55 | 58.55 | 56.35 | 56.61 | 589882.0 |
| Jul 23, 2026 | 57.77 | 59.09 | 57.41 | 57.88 | 615700.0 |
| Jul 22, 2026 | 58.85 | 59.55 | 57.50 | 58.01 | 610075.0 |
| Jul 21, 2026 | 56.42 | 59.73 | 55.05 | 59.53 | 864533.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Globus Medical, Inc. | 83.32 |
| Recursion Pharmaceuticals, Inc. | 3.57 |
| Anika Therapeutics, Inc. | 21.44 |
| Perspective Therapeutics, Inc. | 3.27 |
| Teleflex, Inc. | 139.72 |
Price Related Metrics
| PE Ratio | 30.97 |
| PS Ratio | 6.300 |
| PEG Ratio | 0.0957 |
| Price to Book Value | 2.526 |
| Price to Free Cash Flow | 21.33 |
| Earnings Yield | 3.23% |
| Market Cap | 3.507B |
| PEGY Ratio | 0.0957 |
| Operating PE Ratio | 36.58 |
| Normalized PE Ratio | 33.83 |